The AI in oncology market’s growth is due to rise in prevalence of cancer worldwide. AI uses advanced algorithms that can grasp large volumes of data related to route them toward precise diagnosis of cancer, predict disease progression, and give proper prognosis.
Such algorithms have the ability of outperforming human brains by identification of subtle patterns as well as correlations in genetic data, medical imaging, and the other types of patient information.
The key players in AI in oncology industry are devising AI-powered pathology panels for spatial analysis of tumor microenvironment.
They are also exploring the usage of generative AI in single-cell research for stem cell therapies. Continuous innovation is thus one of the AI in oncology market trends, which is making greater strides in the oncology vertical.
Need for precise diagnoses of cancer coupled with customized treatment recommendations are prompting the healthcare personnel to opt for AI. Moreover, AI can speedily analyze complex datasets, which helps oncologists in detection of tumors and deciding the course of treatment.
The clinicians are empowered by AI to make well-informed decisions regarding treatment for cancer. AI-based clinical decision support systems recommend optimized regimens of therapy by learning from outcomes of a large pool of patients.
These recommendations take the patient’s genomic profile of tumor, responses to initial lines of therapy, and various other factors into account. AI in the form of decision-making tool is thus aiding oncologists choose the right drugs, sequencing of therapies, and drug combinations.
However, AI models are bound to incorrectly conclude forged correlation between outcome labels and data features, resulting in ungeneralizable, misleading, and/or biased conclusions. This factor may restrain the AI in oncology market growth during the forecast period.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
As per the WHO, there were 20 million new cancer cases registered worldwide, with 9.7 million individuals succumbing to it. It further states that 20% of the people contract cancer in their lifetime.
Moreover, lung cancer is responsible for 1.8 million fatalities, followed by colorectal cancer. Breast cancer and belly cancer are more prevalent amongst the women.
Increase in the body mass index, lack of physical activity, and higher consumption of tobacco are responsible for higher incidence of cancer worldwide. Adopting AI for detecting cancer will help in starting with the treatment earlier than the normal course. Besides, AI detection has a higher precision quotient as compared to detection by humans.
The developing economies are also witnessing an expansion in healthcare infrastructure along with adoption of AI.
For instance, in July 2021, the Centre for Fourth Industrial Revolution of the World Economic Forum India announced launching the Fourth Industrial Revolution for Sustainable Transformation (FIRST) of the Cancer Care project in order to emphasize advanced technologies such as AI, blockchain, and IoT to deliver easily accessible, affordable, and high-quality cancer care in India.
Need to combat cancer in a faster manner coupled with the developing countries adopting AI is thus driving the AI in oncology market opportunities
Chemotherapy has been used to destroy the rapidly moving cancer cells since the last several years. Integrating AI with chemotherapy helps healthcare personnel in developing the patients’ personalized digital profile, through which the dose can be personalized.
In June 2022, the National University of Singapore (NUS) announced that it had developed CURATE.AI solution, which uses clinical data such as the drug’s dosage, medications, and presence of biomarkers for customizing the patient’s digital profile. This, in turn, offers personalized chemotherapy dosage recommendations.
Additionally, AI models are employed in order to predict chemotherapy responses as well as cancer prognosis.
For instance, in September 2022, the European Society for Medical Oncology (ESMO) Congress 2022 presented a study, in which it highlighted the probability of response to cisplatin-based neoadjuvant chemotherapy for muscle-invasive bladder cancer (MIBC).
AI is increasingly used in breast cancer’s radiographic imaging to facilitate early diagnosis and treatment. In January 2021, the U.S. FDA approved Visage Breast Density medical device and Imagio Breast Imaging System.
Need for speedy detection and treatment of cancer is thus expanding the AI in oncology market size.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest AI in oncology market analysis, North America held the largest share of AI-driven oncology landscape in 2023 and the status quo is expected to remain unchanged during the forecast period. This is attributed to the U.S. emphasizing advanced AI solutions for diagnosing and treating cancer.
Research states that AI curtails MRI scanning time, thereby resulting in cost-cutting and higher patient outcomes. Along these lines, the American Society of Clinical Oncology has stated that there were close to 5% reductions in treatment costs pertaining to medical oncology in the U.S. in 2022 due to usage of AI.
The key players are also strategically collaborating to expedite the invention of therapeutics using AI.
For instance, in November 2021, Sanofi-Aventis U.S. LLC announced a strategic investment of US$ 180 million in Owkin, Inc. to expand its oncology portfolio regarding multiple myeloma, breast cancer, and lung cancer for optimizing clinical trial design and detecting predictive biomarkers for treatment outcomes with the help of AI.
AI is shaping Canadian healthcare as well. The Canadian Cancer Society 9CCS) supports AI applications by funding the research related to early detection of cancer. For instance, in December 2023, the CCS provided funds to four research teams for innovating in early cancer detection, prevention, and care using AI.
The companies specializing in AI-driven oncology solutions are engaged in new product launch to establish a strong foothold in AI-assisted cancer diagnosis.
For instance, in September 2021, Owkin, Inc. announced development of deep-learning model capable of predicting health outcomes regarding hepatocellular carcinoma.
This model was an outcome of the company’s collaboration with researchers from Cleveland Clinic. Furthermore, in August 2022, Medtronic plc introduced GI GeniusTM intelligent endoscopy module all over India.
Powered by AI, it helps the healthcare personnel in detecting colorectal cancer through improved visualization at the time of colonoscopy.
Paige.AI, Tempus, Ibex Medical Analytics, PathAI, Proscia Inc., DeepMind, SOPHiA GENETICS, Enlitic, Prognos Health, and Inspirata, Inc. are some of the key participants covered in the AI in oncology market report.
These companies have been profiled based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2023 | US$ 1.3 Bn |
| Market Forecast (Value) in 2034 | US$ 7.7 Bn |
| Growth Rate (CAGR) | 16.8% |
| Forecast Period | 2024-2034 |
| Historical Data Available for | 2020-2022 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 1.3 Bn in 2023
It is projected to advance at a CAGR of 16.8% from 2024 to 2034
Growing prevalence of cancer with speedy adoption of AI by developing economies and advancements in AI
Cancer hospitals segment accounted for the largest share in 2023
North America was the dominant region in 2023
Paige.AI, Tempus, Ibex Medical Analytics, PathAI, Proscia Inc., DeepMind, SOPHiA GENETICS, Enlitic, Prognos Health, and Inspirata, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: AI in Oncology Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. AI in Oncology Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product /Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global AI in Oncology Market Analysis and Forecast, by Cancer Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Cancer Type, 2020-2034
6.3.1. Lung Cancer
6.3.2. Breast Cancer
6.3.3. Colorectal Cancer
6.3.4. Ovarian Cancer
6.3.5. Others
6.4. Market Attractiveness Analysis, by Cancer Type
7. Global AI in Oncology Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Diagnosis
7.3.2. Treatment Selection
7.3.3. Drug Discovery
7.3.4. Patient Management and Care
7.4. Market Attractiveness Analysis, by Application
8. Global AI in Oncology Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals & Clinics
8.3.2. Cancer Hospitals
8.3.3. Research Institutes
8.4. Market Attractiveness Analysis, by End-user
9. Global AI in Oncology Market Analysis and Forecast, by Region
9.1. Introduction
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Region, 2020-2034
9.3.1. North America
9.3.2. Europe
9.3.3. Asia Pacific
9.3.4. Latin America
9.3.5. Middle East & Africa
9.4. Market Attractiveness Analysis, by Region
10. North America AI in Oncology Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Cancer Type, 2020-2034
10.3.1. Lung Cancer
10.3.2. Breast Cancer
10.3.3. Colorectal Cancer
10.3.4. Ovarian Cancer
10.3.5. Others
10.4. Market Value Forecast, by Application, 2020-2034
10.4.1. Diagnosis
10.4.2. Treatment Selection
10.4.3. Drug Discovery
10.4.4. Patient Management and Care
10.5. Market Value Forecast, by End-user, 2020-2034
10.5.1. Hospitals & Clinics
10.5.2. Cancer Hospitals
10.5.3. Research Institutes
10.6. Market Value Forecast, by Country, 2020-2034
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Cancer Type
10.7.2. By Application
10.7.3. By End-user
10.7.4. By Country
11. Europe AI in Oncology Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Cancer Type, 2020-2034
11.3.1. Lung Cancer
11.3.2. Breast Cancer
11.3.3. Colorectal Cancer
11.3.4. Ovarian Cancer
11.3.5. Others
11.4. Market Value Forecast, by Application, 2020-2034
11.4.1. Diagnosis
11.4.2. Treatment Selection
11.4.3. Drug Discovery
11.4.4. Patient Management and Care
11.5. Market Value Forecast, by End-user, 2020-2034
11.5.1. Hospitals & Clinics
11.5.2. Cancer Hospitals
11.5.3. Research Institutes
11.6. Market Value Forecast, by Country/Sub-region, 2020-2034
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Cancer Type
11.7.2. By Application
11.7.3. By End-user
11.7.4. By Country/Sub-region
12. Asia Pacific AI in Oncology Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Cancer Type, 2020-2034
12.3.1. Lung Cancer
12.3.2. Breast Cancer
12.3.3. Colorectal Cancer
12.3.4. Ovarian Cancer
12.3.5. Others
12.4. Market Value Forecast, by Application, 2020-2034
12.4.1. Diagnosis
12.4.2. Treatment Selection
12.4.3. Drug Discovery
12.4.4. Patient Management and Care
12.5. Market Value Forecast, by End-user, 2020-2034
12.5.1. Hospitals & Clinics
12.5.2. Cancer Hospitals
12.5.3. Research Institutes
12.6. Market Value Forecast, by Country/Sub-region, 2020-2034
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Cancer Type
12.7.2. By Application
12.7.3. By End-user
12.7.4. By Country/Sub-region
13. Latin America AI in Oncology Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Cancer Type, 2020-2034
13.3.1. Lung Cancer
13.3.2. Breast Cancer
13.3.3. Colorectal Cancer
13.3.4. Ovarian Cancer
13.3.5. Others
13.4. Market Value Forecast, by Application, 2020-2034
13.4.1. Diagnosis
13.4.2. Treatment Selection
13.4.3. Drug Discovery
13.4.4. Patient Management and Care
13.5. Market Value Forecast, by End-user, 2020-2034
13.5.1. Hospitals & Clinics
13.5.2. Cancer Hospitals
13.5.3. Research Institutes
13.6. Market Value Forecast, by Country/Sub-region, 2020-2034
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Cancer Type
13.7.2. By Application
13.7.3. By End-user
13.7.4. By Country/Sub-region
14. Middle East & Africa AI in Oncology Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Cancer Type, 2020-2034
14.3.1. Lung Cancer
14.3.2. Breast Cancer
14.3.3. Colorectal Cancer
14.3.4. Ovarian Cancer
14.3.5. Others
14.4. Market Value Forecast, by Application, 2020-2034
14.4.1. Diagnosis
14.4.2. Treatment Selection
14.4.3. Drug Discovery
14.4.4. Patient Management and Care
14.5. Market Value Forecast, by End-user, 2020-2034
14.5.1. Hospitals & Clinics
14.5.2. Cancer Hospitals
14.5.3. Research Institutes
14.6. Market Value Forecast, by Country/Sub-region, 2020-2034
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Cancer Type
14.7.2. By Application
14.7.3. By End-user
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2023)
15.3. Company Profiles
15.3.1. Paige.AI
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Tempus
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Ibex Medical Analytics
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. PathAI
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. Proscia Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. DeepMind
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. SOPHiA GENETICS
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Enlitic
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Prognos Health
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. Inspirata, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview
List of Tables
Table 01: Global AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 02: Global AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 03: Global AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 04: Global AI in Oncology Market Size (US$ Mn) Forecast, by Region, 2020-2034
Table 05: North America AI in Oncology Market Size (US$ Mn) Forecast, by Country, 2020-2034
Table 06: North America AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 07: North America AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 08: North America AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 09: Europe AI in Oncology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 10: Europe AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 11: Europe AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 12: Europe AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 13: Asia Pacific AI in Oncology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 14: Asia Pacific AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 15: Asia Pacific AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 16: Asia Pacific AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 17: Latin America AI in Oncology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 18: Latin America AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 19: Latin America AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 20: Latin America AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
Table 21: Middle East & Africa AI in Oncology Market Size (US$ Mn) Forecast, by Country/Sub-region, 2020-2034
Table 22: Middle East & Africa AI in Oncology Market Size (US$ Mn) Forecast, by Cancer Type, 2020-2034
Table 23: Middle East & Africa AI in Oncology Market Size (US$ Mn) Forecast, by Application, 2020-2034
Table 24: Middle East & Africa AI in Oncology Market Size (US$ Mn) Forecast, by End-user, 2020-2034
List of Figures
Figure 01: Global AI in Oncology Market Size (US$ Mn) and Distribution (%), by Region, 2023 and 2034
Figure 02: Global AI in Oncology Market Revenue (US$ Mn), by Cancer Type, 2023
Figure 03: Global AI in Oncology Market Value Share, by Cancer Type, 2023
Figure 04: Global AI in Oncology Market Revenue (US$ Mn), by Application, 2023
Figure 05: Global AI in Oncology Market Value Share, by Application, 2023
Figure 06: Global AI in Oncology Market Revenue (US$ Mn), by End-user, 2023
Figure 07: Global AI in Oncology Market Value Share, by End-user, 2023
Figure 08: Global AI in Oncology Market Value Share, by Region, 2023
Figure 09: Global AI in Oncology Market Value (US$ Mn) Forecast, 2020-2034
Figure 10: Global AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 11: Global AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 12: Global AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 13: Global AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 14: AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 15: Global AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Figure 16: Global AI in Oncology Market Value Share Analysis, by Region, 2023 and 2034
Figure 17: Global AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 18: North America AI in Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 19: North America AI in Oncology Market Attractiveness Analysis, by Country, 2024-2034
Figure 20: North America AI in Oncology Market Value Share Analysis, by Country, 2023 and 2034
Figure 21: North America AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 22: North America AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 23: North America AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 24: North America AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 25: North America AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 26: North America AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Figure 27: Europe AI in Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 28: Europe AI in Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 29: Europe AI in Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 30: Europe AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 31: Europe AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 32: Europe AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 33: Europe AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 34: Europe AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 35: Europe AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Figure 36: Asia Pacific AI in Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 37: Asia Pacific AI in Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 38: Asia Pacific AI in Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 39: Asia Pacific AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 40: Asia Pacific AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 41: Asia Pacific AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 42: Asia Pacific AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 43: Asia Pacific AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 44: Asia Pacific AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Figure 45: Latin America AI in Oncology Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 46: Latin America AI in Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 47: Latin America AI in Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 48: Latin America AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 49: Latin America AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 50: Latin America AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 51: Latin America AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 52: Latin America AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 53: Latin America AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Figure 54: Middle East & Africa AI in Oncology Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2020-2034
Figure 55: Middle East & Africa AI in Oncology Market Attractiveness Analysis, by Country/Sub-region, 2024-2034
Figure 56: Middle East & Africa AI in Oncology Market Value Share Analysis, by Country/Sub-region, 2023 and 2034
Figure 57: Middle East & Africa AI in Oncology Market Value Share Analysis, by Cancer Type, 2023 and 2034
Figure 58: Middle East & Africa AI in Oncology Market Value Share Analysis, by Application, 2023 and 2034
Figure 59: Middle East & Africa AI in Oncology Market Value Share Analysis, by End-user, 2023 and 2034
Figure 60: Middle East & Africa AI in Oncology Market Attractiveness Analysis, by Region, 2024-2034
Figure 61: Middle East & Africa AI in Oncology Market Attractiveness Analysis, by Application, 2024-2034
Figure 62: Middle East & Africa AI in Oncology Market Attractiveness Analysis, by End-user, 2024-2034
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
AI in Oncology Market
*86 figures and 60 tables includes